Significance of "Abnormal" Nadir Growth Hormone Levels after Oral Glucose in Postoperative Patients with Acromegaly in Remission with Normal Insulin-Like Growth Factor-I Levels

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 2, 2004, Pages 495-500

  Freda, Pamela U ^a   Nuruzzaman, Abu T ^b   Reyes, Carlos M ^b   Sundeen, Robert E ^b   Post, Kalmon D ^b  

^a College of Physicians and Surgeons ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADOLESCENT; ADULT; AGED; ARTICLE; BIOCHEMISTRY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROWTH HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; STATISTICAL SIGNIFICANCE;

ACROMEGALY; ADULT; AGED; ARGININE; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; REMISSION INDUCTION;

EID: 1442352333     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031316     Document Type: Article

References (27)

1. Freda PU, Post KD, Powell JS, Wardlaw SL 1998 Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. J Clin Endocrinol Metab 83:3808-3816
2. Dimaraki EV, Jaffe CA, DeMott-Friberg R, Chandler WF, Barkan AL 2002 Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. J Clin Endocrinol Metab 87:3537-3542
3. Freda PU, Landman RE, Sundeen RE, Post KD 2001 Gender and age in the biochemical assessment of cure of acromegaly. Pituitary 4:163-171
4. Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD, Thorner MO 1994 Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab 78:1312-1319
5. Earll JM, Sparks LL, Forsham PH 1967 Glucose suppression of serum growth hormone in the diagnosis of acromegaly. JAMA 201:628-630
6. Lawrence AM, Goldfine ID, Kirsteins L 1970 Growth hormone dynamics in acromegaly. J Clin Endocrinol Metab 31:239-247
7. Shibasaki T, Masuda A, Hotta M, Yamauchi N, Hizuka N, Takano K, Demura H, Shizume K 1989 Effects of ingestion of glucose on GH and TSH secretion: evidence for stimulation of somatostatin release from the Hypothalamus by acute hyperglycemia in normal man and its impairment in acromegalic patients. Life Sci 44:431-438
8. Freda PU 2003 Current concepts in the biochemical assessment of the patient with acromegaly. Growth Horm IGF Res 13:171-184
9. Maccario M, Procopio M, Grottoli S, Oleandri SE, Razzore P, Camanni F, Ghigo E 1995 In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose. J Clin Endocrinol Metab 80:3774-3778
10. Bonora E, Moghetti P, Zenere M, Querena M, Tosi F, Corgnati A, Muggeo M 1990 Plasma concentrations of growth hormone during hyperglycemic clamp with or without somatostatin infusion in obese subjects. J Clin Endocrinol Metab 70:1732-1734
11. Kristof RA, Neuloh G, Redel L, Klingmuller D, Schramm J 2002 Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission. J Neurosurg 97:1282-1286
12. Hanew K, Sasaki A, Mouri T, Yoshinaga K 1980 Plasma growth hormone and prolactin responses to TRH and arginine given before and during bromocriptine therapy to patients with acromegaly. Acta Endocrinol 95:298-307
13. Alba-Roth J, Muller OA, Schopohl J, von Werder K 1988 Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metab 67:1186-1189
14. Masuda A, Shibasaki T, Nakahara M, Imaki T, Kiyosawa Y, Jibiki K, Demura H, Shizume K, Ling N 1985 The effect of glucose on growth hormone (GH) -releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab 60:523-526
15. Peacey SR, Toogood AA, Shalet SM 1998 Hypothalamic dysfunction in "cured" acromegaly is treatment modality dependent. J Clin Endocrinol Metab 83:1682-1686
16. Murray RD, Peacey SR, Rahim A, Toogood AA, Thorner MO, Shalet SM 2001 The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients. Clin Endocrinol (Oxf) 54:37-44
17. Ho KY, Weissberger AJ 1994 Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy. Clin Endocrinol (Oxf) 41:75-83
18. Hartman ML, Veldhuis JD, Vance ML, Faria AC, Furlanetto RW, Thorner MO 1990 Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy. J Clin Endocrinol Metab 70:1375-1384
19. Peacey SR, Toogood AA, Veldhuis JD, Thorner MO, Shalet SM 2001 The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy. J Clin Endocrinol Metab 86:259-266
20. Ho PJ, Jaffe CA, Friberg RD, Chandler WF, Barkan AL 1994 Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors. J Clin Endocrinol Metab 78:1403-1410
21. Arafah BM, Rosenzweig JL, Fenstermaker R, Salazar R, McBride CE, Selman W 1987 Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly. J Lab Clin Med 109:346-354
22. Biermasz NR, Smit JW, van Dulken H, Roelfsema F 2002 Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly. Clin Endocrinol (Oxf) 56:313-319
23. Freda PU, Wardlaw SL, Post KD 1998 Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. J Neurosurg 89:353-358
24. Swearingen B, Barker 2nd FG, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT 1998 Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:3419-3426
25. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB 1998 Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 83:3411-3418
26. Biermasz NR, van Dulken H, Roelfsema F 2000 Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. J Clin Endocrinol Metab 85:4596-4602
27. Kreutzer J, Vance ML, Lopes MB, Laws Jr ER 2001 Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab 86:4072-4077